surmount tirzepatide trials SURMOUNT-5: shows superior weight loss over semaglutide SURMOUNT-2: Tirzepatide confers about 15%

I give 4 stars because with each injection I get a rash at the site and I still have somewhat of an appetite on this med

GLP-1 agonist drugs enhance this function of GLP-1, achieving weight control effects by suppressing appetite

propensity-matched 118,993 GLP-1 RA users to 118,993 non-users in the TriNetX network and found a modest but statistically robust 2123% higher hazard of new-onset hypersomnolence at 1 and 5 years

A 2022 study found that many people regain weight after stopping the drug on average, two-thirds of the weight they lost within a year

60% Percent of ASO members achieving diabetes reversal More than half of ASO patients who are with Virta for one year achieve diabetes reversallowering blood glucose below the diabetes threshold while removing all diabetes-specific medications

Well see consumer businesses reshape their portfolios to manage near-term risk